Investor FAQs

Investor FAQs

Show All
Where does Precision Therapeutics stock trade?
Precision Therapeutics common shares are traded on Nasdaq Capital Market under the ticker symbol AIPT.
When was Precision Therapeutics incorporated?
Precision Therapeutics was incorporated under the name BioDrain Medical, Inc. on April 23, 2002, in the state of Minnesota.
When did the company change its name to Precision Therapeutics?
Precision Therapeutics changed from Skyline Medical, Inc. effective February 2, 2018.
When did Precision Therapeutics become a public company?
Precision Therapeutics became a public company on October 19, 2009. It began trading on the Nasdaq in August 2015.
How can I get the current Precision Therapeutics stock price?
Price information as well as other information regarding the Precision Therapeutics stock is provided by its stock exchange platform and can be found on our Stock Information page.
How can I purchase stock in Precision Therapeutics?
Through a licensed stock broker or by using an online trading account.
How many shares of Precision Therapeutics' stock are outstanding?
As of March 19, 2018, the Company had 11,804,073 shares of common stock outstanding.  For an updated shares outstanding figure, please visit our SEC Filings.
Who is Precision Therapeutics' transfer agent and how does a registered shareholder contact the agent regarding account information?
Corporate Stock Transfer, Inc. 3200 Cherry Creek South Drive, Suite 430, Denver, CO 80209; Tel-303-282-4800.
Whom should I contact regarding my stock certificate(s)?
Please contact the Company’s transfer agent regarding your stock certificate.
When does Precision Therapeutics' fiscal year end?
Precision Therapeutics' fiscal year ends on December 31.
How do I get a copy of the Annual Report?
Please visit the Financial Information section of our website to obtain the latest Annual Report.
What is Precision Therapeutics' CUSIP number?
Precision Therapeutics' CUSIP number is 83084T101.
Where is the company located?
2915 Commers Drive, Suite 900
Eagan, MN 55121
Who are Precision Therapeutics' independent auditors?
Precision Therapeutics' independent auditors are Deloitte & Touche LLP.
Who is Precision Therapeutics' outside legal counsel?
Martin Rosenbaum, Maslon, Edelman, Borman & Brand, LLP, 3300 Wells Fargo Center, 90 South Seventh Street, Minneapolis, MN 55402, Tel-612-672-8300.
How do I contact Precision Therapeutics' Investor Relations?

Please contact: 
Elizabeth Barker
KCSA Strategic Communications
ebarker@kcsa.com